{"content":"<li class=\"n-box-item date-title\" data-end=\"1528948799\" data-start=\"1528862400\" data-txt=\"Monday, December 23, 2019\">Wednesday, June 13, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3363805\" data-ts=\"1528929965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVLV\" target=\"_blank\">EVLV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363805-evine-liveplus-6_8-cfo-discloses-share-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evine Live +6.8% as CFO discloses share purchase</a></h4><ul>   <li>Evine Live (NASDAQ:<a href='https://seekingalpha.com/symbol/EVLV' title='EVINE Live Inc.'>EVLV</a>) is <font color='green'>up 6.8%</font> after hours following an <a href=\"https://seekingalpha.com/filing/4066160\" target=\"_blank\">SEC filing</a> indicating its chief financial officer bought 5,000 shares.</li>    <li>Diana Purcel, executive VP and CFO, bought the shares on Monday at an average price of $1.2064 each.</li>    <li>That brings her holdings to 55,000 shares, according to the filing.</li>    <li>Shares had <font color='red'>fallen 2.5%</font> during the regular market session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363805\" data-linked=\"Evine Live +6.8% as CFO discloses share purchase\" data-tweet=\"$EVLV $IMBI - Evine Live +6.8% as CFO discloses share purchase https://seekingalpha.com/news/3363805-evine-liveplus-6_8-cfo-discloses-share-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3363805-evine-liveplus-6_8-cfo-discloses-share-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363795\" data-ts=\"1528925737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363795-after-hours-gainers-losers-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/13/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a>&nbsp;<font color='green'>+11.6%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/KRP' title='Kimbell Royalty Partners LP'>KRP</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/WUBA' title='58.com Inc.'>WUBA</a>&nbsp;<font color='green'>+3.4%</font>. <a href='https://seekingalpha.com/symbol/CATM' title='Cardtronics plc'>CATM</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a>&nbsp;<font color='green'>+2.7%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='red'>-21.0%</font>. <a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>&nbsp;<font color='red'>-4.5%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/RDNT' title='RadNet, Inc.'>RDNT</a>&nbsp;<font color='red'>-3.1%.&nbsp;</font><a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>&nbsp;<font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/EIGI' title='Endurance International Group Holdings, Inc.'>EIGI</a>&nbsp;<font color='red'>-2.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363795\" data-linked=\"After Hours Gainers / Losers (06/13/2018)\" data-tweet=\"$TLGT $TLGT $KRP - After Hours Gainers / Losers (06/13/2018) https://seekingalpha.com/news/3363795-after-hours-gainers-losers-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363795-after-hours-gainers-losers-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363785\" data-ts=\"1528923425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363785-mylan-down-4-after-hours-on-expected-crl-for-generic-advair-diskus-application\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan down 4% after hours on expected CRL for generic Advair Diskus application</a></h4><ul><li>Mylan N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>) slips&nbsp;<font color='red'>4%</font>&nbsp;after hours on its <a href=\"https://www.sec.gov/Archives/edgar/data/1623613/000119312518191726/d609279d8k.htm\" target=\"_blank\">disclosure</a> that it will receive a CRL regarding its pending marketing application for a generic version of GlaxoSmithKline's (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a>) asthma med Advair Diskus (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder).</li><li>The company says the FDA informed it that it identified minor deficiencies in the application. It will assess the impact from the situation on 2018 guidance after it reviews the CRL.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363785\" data-linked=\"Mylan down 4% after hours on expected CRL for generic Advair Diskus application\" data-tweet=\"$MYL $MYL $GSK - Mylan down 4% after hours on expected CRL for generic Advair Diskus application https://seekingalpha.com/news/3363785-mylan-down-4-after-hours-on-expected-crl-for-generic-advair-diskus-application?source=tweet\" data-url=\"https://seekingalpha.com/news/3363785-mylan-down-4-after-hours-on-expected-crl-for-generic-advair-diskus-application\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363783\" data-ts=\"1528922976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363783-fda-oks-teligents-generic-diflorasone-diacetate-ointment-shares-up-10-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Teligent&#39;s generic diflorasone diacetate ointment; shares up 10% after hours</a></h4><ul><li>Teligent (NASDAQ:<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;after hours in response to the FDA <a href=\"https://seekingalpha.com/pr/17191641-teligent-inc-announces-fda-approval-diflorasone-diacetate-ointment-0_05-percent\" target=\"_blank\">approval </a>of its generic Diflorasone Diacetate Ointment 0.05%. Per IQVIA, the U.S. market is ~$14M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363783\" data-linked=\"FDA OKs Teligent&#39;s generic diflorasone diacetate ointment; shares up 10% after hours\" data-tweet=\"$TLGT - FDA OKs Teligent&#39;s generic diflorasone diacetate ointment; shares up 10% after hours https://seekingalpha.com/news/3363783-fda-oks-teligents-generic-diflorasone-diacetate-ointment-shares-up-10-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3363783-fda-oks-teligents-generic-diflorasone-diacetate-ointment-shares-up-10-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363778\" data-ts=\"1528922462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363778-vanity-fair-zucker-staying-cnn-through-20-election\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanity Fair: Zucker staying at CNN through &#39;20 election</a></h4><ul>   <li>A favorite punching bag of President Trump isn't going anywhere for a while: Jeff Zucker will <a href=\"https://www.vanityfair.com/news/2018/06/jeff-zucker-renews-at-cnn-through-the-2020-election\" target=\"_blank\">stay at the helm of CNN through the 2020 election</a>, firming up one piece of the post-AT&amp;T Time Warner regime, <i>Vanity Fair</i> reports.</li>    <li>Zucker signed a deal months ago, according to the report. For those looking for the drama in any business story, it's quite a turnabout from the very recent prospect that AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) would be denied an acquisition of Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) without selling CNN entirely.</li>    <li>The move erases one of the big question marks about who would sail on with the soon-to-be-combined media/telecom giant.</li>    <li>Zucker was Trump's boss when he ran NBC during the salad days of Trump's reality competition <i>The Apprentice.</i> (\"I made Jeff Zucker,\" Trump has reportedly said.)</li>    <li>AT&amp;T executives were made aware of Zucker's retention deal at the time it was made, and they were supportive, Joe Pompeo reports.</li>    <li>AT&amp;T <font color='red'>fell 6.2%</font> during the regular session today; it's <font color='green'>up 0.1%</font> after hours. <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='green'>rose 1.8%</font> during market hours and is <font color='green'>up 0.2%</font> postmarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363778\" data-linked=\"Vanity Fair: Zucker staying at CNN through &#39;20 election\" data-tweet=\"$T $T $TWX - Vanity Fair: Zucker staying at CNN through &#39;20 election https://seekingalpha.com/news/3363778-vanity-fair-zucker-staying-cnn-through-20-election?source=tweet\" data-url=\"https://seekingalpha.com/news/3363778-vanity-fair-zucker-staying-cnn-through-20-election\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363777\" data-ts=\"1528922040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQMS\" target=\"_blank\">AQMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363777-aqua-metalsminus-10-after-announcing-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aqua Metals -10% after announcing share offering</a></h4><ul>     <li>Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals'>AQMS</a>) <font color='red'>-9.8%</font> after-hours on news it plans a <a href=\"https://seekingalpha.com/pr/17191607-aqua-metals-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of an unspecified number of common shares.</li>     <li>AQMS says it plans to use the proceeds for working capital, which could include capex related to addressing operational efficiencies and the expansion of production  activities at its initial AquaRefining facility in Nevada, as well as general corporate purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363777\" data-linked=\"Aqua Metals -10% after announcing share offering\" data-tweet=\"$AQMS - Aqua Metals -10% after announcing share offering https://seekingalpha.com/news/3363777-aqua-metalsminus-10-after-announcing-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3363777-aqua-metalsminus-10-after-announcing-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363772\" data-ts=\"1528921514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOL\" target=\"_blank\">TOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363772-fed-day-proves-rough-one-for-homebuilders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fed day proves a rough one for homebuilders</a></h4><ul><li>The homebuilders were under pressure all day long and added to losses following the Fed's 25 basis point rate hike <a href=\"https://seekingalpha.com/news/3363729-fed-signals-two-rate-hikes-year\" target=\"_blank\">and signal that </a>two more moves were coming before year-end.</li><li>The 10-year yield briefly surged back above 3%, but settled up just one basis point at 2.975%.</li><li>The iShares U.S. Home Construction ETF (<a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a> <font color='red'>-3.7%</font>).</li><li>Individual players: Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a> <font color='red'>-4.3%</font>), Pulte (<a href='https://seekingalpha.com/symbol/PHM' title='PulteGroup, Inc.'>PHM</a> <font color='red'>-6.7%</font>), D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color='red'>-4.2%</font>), KB Home (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='red'>-7.3%</font>), Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='red'>-4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363772\" data-linked=\"Fed day proves a rough one for homebuilders\" data-tweet=\"$TOL $ITB $TOL - Fed day proves a rough one for homebuilders https://seekingalpha.com/news/3363772-fed-day-proves-rough-one-for-homebuilders?source=tweet\" data-url=\"https://seekingalpha.com/news/3363772-fed-day-proves-rough-one-for-homebuilders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363760\" data-ts=\"1528920558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBIO\" target=\"_blank\">HBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363760-harvard-bio-launches-new-inhalation-and-exposure-system-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harvard Bio launches new inhalation and exposure system; shares up 1% after hours</a></h4><ul><li>Harvard Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/HBIO' title='Harvard Bioscience, Inc.'>HBIO</a>) <a href=\"https://seekingalpha.com/pr/17191554-harvard-bioscience-subsidiary-data-sciences-international-launches-inhalation-exposure-system\" target=\"_blank\">announces </a>that subsidiary Data Sciences International has launched a new inhalation and exposure system, the DSI Buxco.</li><li>The company says the system enables researchers to perform accurate real-time respiration monitoring during exposure via its FinePoint software.</li><li>The market for inhaled drugs is ~$48B.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363760\" data-linked=\"Harvard Bio launches new inhalation and exposure system; shares up 1% after hours\" data-tweet=\"$HBIO - Harvard Bio launches new inhalation and exposure system; shares up 1% after hours https://seekingalpha.com/news/3363760-harvard-bio-launches-new-inhalation-and-exposure-system-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3363760-harvard-bio-launches-new-inhalation-and-exposure-system-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363757\" data-ts=\"1528920301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVR\" target=\"_blank\">IVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363757-mortgage-reits-in-red-fed-signals-two-rate-hikes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage REITs in the red as Fed signals two more rate hikes</a></h4><ul><li>The Fed boosted rates 25 basis points earlier - no surprise there. Somewhat surprising though, were the \"dots,\" <a href=\"https://seekingalpha.com/news/3363729-fed-signals-two-rate-hikes-year\" target=\"_blank\">which now indicate </a>the Fed's median expectation as being for two more moves this year. That would be four total for 2018 vs. the three that had been previously anticipated.</li><li>Among mortgage REITs (<a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a> <font color='red'>-0.5%</font>) Invesco Mortgage (<a href='https://seekingalpha.com/symbol/IVR' title='Invesco Mortgage Capital Inc.'>IVR</a> <font color='red'>-1.4%</font>), Annaly Capital (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> <font color='red'>-0.9%</font>), Armour Residential (<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> <font color='red'>-0.6%</font>), AGNC Investment (<a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a> <font color='red'>-0.7%</font>), Dynex Capital (<a href='https://seekingalpha.com/symbol/DX' title='Dynex Capital Inc.'>DX</a> <font color='red'>-1%</font>), Two Harbors (<a href='https://seekingalpha.com/symbol/TWO' title='Two Harbors Investment Corp.'>TWO</a> <font color='red'>-1%</font>), Western Asset (<a href='https://seekingalpha.com/symbol/WMC' title='Western Asset Mortgage Capital Corporation'>WMC</a> <font color='red'>-0.9%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3363757\" data-linked=\"Mortgage REITs in the red as Fed signals two more rate hikes\" data-tweet=\"$IVR $REM $IVR - Mortgage REITs in the red as Fed signals two more rate hikes https://seekingalpha.com/news/3363757-mortgage-reits-in-red-fed-signals-two-rate-hikes?source=tweet\" data-url=\"https://seekingalpha.com/news/3363757-mortgage-reits-in-red-fed-signals-two-rate-hikes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363754\" data-ts=\"1528920107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363754-comcast-unveils-65b-cash-bid-for-fox-assets-setting-up-disney-war\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast unveils $65B cash bid for Fox assets, setting up Disney war</a></h4><ul>   <li>With the market closing and AT&amp;T's Time Warner victory still hot from the oven, Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) has <a href=\"https://seekingalpha.com/pr/17191551-comcast-makes-superior-cash-proposal-acquire-twenty-first-century-fox-spinoff-new-fox\" target=\"_blank\">unveiled its bid for the media assets</a> of Twenty-First Century Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>).</li>    <li>It's a total bid of $65B, $35/share in cash, a premium of about 19% to Disney's offer.</li>    <li>Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) has a stock deal for the entertainment assets worth about $52.4B, and all signs point to a bidding war, with the prospect of Fox's IP being a must-have in the consolidated media/telecom future.</li>    <li>It's a bid intended to move the needle on Fox, which reportedly spurned a similarly higher bid from Comcast before with Rupert Murdoch preferring the tax-free transfer of Disney stock instead. The size of this bid might change his mind, or at least put the fear of that outcome into Disney.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+0.5%</font>; <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> flat; <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+0.6%</font>; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+0.7%</font>. During the regular session, <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>gained 7.5%</font>; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>gained 7.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363754\" data-linked=\"Comcast unveils $65B cash bid for Fox assets, setting up Disney war\" data-tweet=\"$CMCSA $CMCSA $FOX - Comcast unveils $65B cash bid for Fox assets, setting up Disney war https://seekingalpha.com/news/3363754-comcast-unveils-65b-cash-bid-for-fox-assets-setting-up-disney-war?source=tweet\" data-url=\"https://seekingalpha.com/news/3363754-comcast-unveils-65b-cash-bid-for-fox-assets-setting-up-disney-war\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363749\" data-ts=\"1528919422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TREE\" target=\"_blank\">TREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363749-lending-tree-drops-analyst-sees-near-term-choppiness-in-mortgage-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lending Tree drops as analyst sees near-term choppiness in mortgage business</a></h4><ul><li>LendingTree (NASDAQ:<a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a>)&nbsp;<font color='red'>-7.7%</font>&nbsp;in late afternoon trading after an analyst writes that he's \"slightly less optimistic about near-term growth trend in mortgage,\" Bloomberg reports, citing a note by analyst Stephen Sheldon.</li><li>TREE's mortgage business should improve in 2019, Sheldon says.</li><li>Converting purchase leads has been more difficult and taking longer than converting refinancing leads, management said at the recent Blair conference.</li><li>TREE has 9 buys, 3 holds, 1 sell; average price target $335: Bloomberg data.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3355805-lendingtree-buy-credit-service-firm-20_75m\" target=\"_blank\">LendingTree to buy credit service firm for $20.75M</a> (May 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363749\" data-linked=\"Lending Tree drops as analyst sees near-term choppiness in mortgage business\" data-tweet=\"$TREE - Lending Tree drops as analyst sees near-term choppiness in mortgage business https://seekingalpha.com/news/3363749-lending-tree-drops-analyst-sees-near-term-choppiness-in-mortgage-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3363749-lending-tree-drops-analyst-sees-near-term-choppiness-in-mortgage-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363748\" data-ts=\"1528918955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363748-turtle-beach-rallies-onplus-11_7-oppenheimer-stays-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turtle Beach rallies on, +11.7% as Oppenheimer stays bullish</a></h4><ul>   <li>Turtle Beach's (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) hot spring continues, with an <font color='green'>11.7% gain</font> today after Oppenheimer reiterates an Outperform rating based on meeting management at E3.</li>    <li>CEO Juergen Stark and CFO John Hanson met with analyst Andrew Uerkwitz and pointed to its improving balance sheet and strong position in the market for console headsets. Product quality will allow it to maintain a highly defensible lead over rivals, the two said. (h/t Bloomberg)</li>    <li>Shares are <font color='green'>up 222%</font> in just over two months, but are the S&amp;P Total Market leader in YTD percentage gains with 10-bagger performance (the stock started the year at $1.81/share and today sits at $22.38).</li>    <li>Uerkwitz and team may need to update a price target of $12 (which had been boosted to that point from $4 on May 10, just before a sharp leg up in the stock's performance).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363748\" data-linked=\"Turtle Beach rallies on, +11.7% as Oppenheimer stays bullish\" data-tweet=\"$HEAR - Turtle Beach rallies on, +11.7% as Oppenheimer stays bullish https://seekingalpha.com/news/3363748-turtle-beach-rallies-onplus-11_7-oppenheimer-stays-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3363748-turtle-beach-rallies-onplus-11_7-oppenheimer-stays-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363745\" data-ts=\"1528918599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363745-acadia-pharma-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia Pharma down 9%</a></h4><ul><li>ACADIA Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-8.8%</font>) slumps almost 40% higher volume following its corporate presentation at the Goldman Sachs Healthcare Conference.</li><li>Shares have been mired in a nine-month downtrend with shares shedding about 60% of their value. Abrupt selloffs occurred in February, in response to below-consensus sales of NUPLAZID (pimavanserin) in Q4, and April in reaction to the news that the FDA was re-examining safety data related to the Parkinson's disease psychosis med.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344387-acadia-pharma-17-percent-premarket-nuplazid-safety-concerns\" target=\"_blank\">Acadia Pharma down 17% premarket on Nuplazid safety concerns</a> (April 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335178-acadia-17-percent-q4-nuplazid-sales-disappoint\" target=\"_blank\">ACADIA down 17% after Q4 Nuplazid sales disappoint</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363745\" data-linked=\"Acadia Pharma down 9%\" data-tweet=\"$ACAD - Acadia Pharma down 9% https://seekingalpha.com/news/3363745-acadia-pharma-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3363745-acadia-pharma-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363744\" data-ts=\"1528917583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363744-merrimack-pharma-breaks-free-of-consolidation-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack Pharma breaks free of consolidation, up 10%</a></h4><ul><li>Thinly traded micro cap Merrimack Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='green'>+9.6%</font>) is up on almost a 9x surge in volume, although shares have retraced 9% from the intraday high of $10.53.</li><li>No particular news accounts for the action. Upcoming catalysts are data readouts from Phase 2 studies of MM-121 (seribantumab) in heregulin-positive <a href=\"https://clinicaltrials.gov/ct2/show/NCT02387216?intr=MM-121&amp;spons=merrimack&amp;rank=8\" target=\"_blank\">non-small cell lung cancer </a>and <a href=\"https://clinicaltrials.gov/ct2/show/NCT03241810?intr=MM-121&amp;spons=merrimack&amp;rank=10\" target=\"_blank\">breast cancer</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363744\" data-linked=\"Merrimack Pharma breaks free of consolidation, up 10%\" data-tweet=\"$MACK - Merrimack Pharma breaks free of consolidation, up 10% https://seekingalpha.com/news/3363744-merrimack-pharma-breaks-free-of-consolidation-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3363744-merrimack-pharma-breaks-free-of-consolidation-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363738\" data-ts=\"1528916543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRHC\" target=\"_blank\">TRHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363738-tabula-rasa-closes-medication-management-contract-pace-program-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tabula Rasa closes medication management contract with PACE program; shares up 4%</a></h4><ul><li>Tabula Rasa (<a href='https://seekingalpha.com/symbol/TRHC' title='Tabula Rasa HealthCare'>TRHC</a> <font color='green'>+4.2%</font>) is up on below-average volume on the <a href=\"https://seekingalpha.com/pr/17191482-tabula-rasa-healthcare-s-carekinesis-signs-agreement-total-life-healthcare\" target=\"_blank\">news </a>that subsidiary CareKinesis has closed a contract with St. Bernards Total Life Healthcare, an Arkansas-based PACE program, to provide comprehensive medication management services. Financial terms are not disclosed.</li><li>PACE (Program for All-inclusive Care for the Elderly) is a Medicare and Medicaid benefit for people at least 55 years old who are nursing home eligible. Its aim is to reduce emergency room visits and hospitalizations by keeping participants living in their homes while receiving care.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363738\" data-linked=\"Tabula Rasa closes medication management contract with PACE program; shares up 4%\" data-tweet=\"$TRHC - Tabula Rasa closes medication management contract with PACE program; shares up 4% https://seekingalpha.com/news/3363738-tabula-rasa-closes-medication-management-contract-pace-program-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3363738-tabula-rasa-closes-medication-management-contract-pace-program-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363734\" data-ts=\"1528916236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVTL\" target=\"_blank\">PVTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363734-technology-top-5-gainers-losers-of-2_55-pm-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (06/13/2018)</a></h4><ul>     <li><strong>Gainers</strong>: <a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/APPN' title='Appian Corp.'>APPN</a> <font color='green'>+10%</font>.</li>      <li><strong>Losers</strong>: <a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SE' title='Sea Ltd'>SE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363734\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (06/13/2018)\" data-tweet=\"$PVTL $PVTL $ENPH - Technology - Top 5 Gainers / Losers as of 2.55 PM (06/13/2018) https://seekingalpha.com/news/3363734-technology-top-5-gainers-losers-of-2_55-pm-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363734-technology-top-5-gainers-losers-of-2_55-pm-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363732\" data-ts=\"1528915550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363732-emerging-markets-lower-after-hawkish-fed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emerging markets lower after hawkish Fed</a></h4><ul><li>They're not down by a ton today, but both the Vanguard FTSE Emerging Markets ETF (<a href='https://seekingalpha.com/symbol/VWO' title='Vanguard FTSE Emerging Markets ETF'>VWO</a> <font color='red'>-0.9%</font>) and the iShares MSCI Emerging Markets ETF (<a href='https://seekingalpha.com/symbol/EEM' title='iShares MSCI Emerging Markets ETF'>EEM</a> <font color='red'>-0.9%</font>) suffered notable dips just after 2 ET, when <a href=\"https://seekingalpha.com/news/3363729-fed-signals-two-rate-hikes-year\" target=\"_blank\">the FOMC not just hiked</a> rates by 25 basis points, but signaled it's ready to move two more times this year.</li><li>Prior to that, markets had been undecided on whether we were going to get one or three or four rate hikes in 2018.</li><li>Emerging market debt (<a href='https://seekingalpha.com/symbol/EMB' title='iShares J.P. Morgan USD Emerging Markets Bond ETF'>EMB</a> <font color='red'>-0.5%</font>) also slid as the news hit.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EEM' title='iShares MSCI Emerging Markets ETF'>EEM</a>, <a href='https://seekingalpha.com/symbol/VWO' title='Vanguard FTSE Emerging Markets ETF'>VWO</a>, <a href='https://seekingalpha.com/symbol/IEMG' title='iShares Core MSCI Emerging Markets ETF'>IEMG</a>, <a href='https://seekingalpha.com/symbol/EDC' title='Direxion Daily Emerging Markets Bull 3x Shares ETF'>EDC</a>, <a href='https://seekingalpha.com/symbol/SCHE' title='Schwab Emerging Markets ETF'>SCHE</a>, <a href='https://seekingalpha.com/symbol/EDZ' title='Direxion Daily Emerging Markets Bear 3x Shares ETF'>EDZ</a>, <a href='https://seekingalpha.com/symbol/EMF' title='Templeton Emerging Markets Fund'>EMF</a>, <a href='https://seekingalpha.com/symbol/MSF' title='Morgan Stanley Emerging Markets Fund'>MSF</a>, <a href='https://seekingalpha.com/symbol/ADRE' title='Invesco BLDRS Emerging Markets 50 ADR Index ETF'>ADRE</a>, <a href='https://seekingalpha.com/symbol/EEV' title='ProShares UltraShort MSCI Emerging Markets ETF'>EEV</a>, <a href='https://seekingalpha.com/symbol/EUM' title='ProShares Short MSCI Emerging Markets ETF'>EUM</a>, <a href='https://seekingalpha.com/symbol/EET' title='ProShares Ultra MSCI Emerging Markets ETF'>EET</a>, <a href='https://seekingalpha.com/symbol/SPEM' title='SPDR Portfolio Emerging Markets ETF'>SPEM</a>, <a href='https://seekingalpha.com/symbol/EEME' title='iShares MSCI Emerging Markets EMEA Index ETF'>EEME</a>, <a href='https://seekingalpha.com/symbol/XSOE' title='WisdomTree Emerging Markets ex-State-Owned Enterprises Fund'>XSOE</a>, <a href='https://seekingalpha.com/symbol/DBEM' title='Deutsche X-trackers MSCI Emerging Markets Hedged Equity ETF'>DBEM</a>, <a href='https://seekingalpha.com/symbol/FEM' title='First Trust Emerging Markets AlphaDEX ETF'>FEM</a>, <a href='https://seekingalpha.com/symbol/HEEM' title='iShares Currency Hedged MSCI Emerging Markets ETF'>HEEM</a>, <a href='https://seekingalpha.com/symbol/EWEM' title='Invesco MSCI Emerging Markets Equal Weight ETF'>EWEM</a>, <a href='https://seekingalpha.com/symbol/ROAM' title='Hartford Multifactor Emerging Markets ETF'>ROAM</a>, <a href='https://seekingalpha.com/symbol/ESGE' title='iShares MSCI EM ESG Select ETF'>ESGE</a>, <a href='https://seekingalpha.com/symbol/EDBI' title='Legg Mason Emerging Market Diversified Core ETF'>EDBI</a>, <a href='https://seekingalpha.com/symbol/EMLB' title='iPath Long Enhanced 2x MSCI Emerging Markets Index ETN'>EMLB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3363732\" data-linked=\"Emerging markets lower after hawkish Fed\" data-tweet=\"$VWO $EEM $EMB - Emerging markets lower after hawkish Fed https://seekingalpha.com/news/3363732-emerging-markets-lower-after-hawkish-fed?source=tweet\" data-url=\"https://seekingalpha.com/news/3363732-emerging-markets-lower-after-hawkish-fed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363730\" data-ts=\"1528914571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363730-dollar-on-move-after-fed-signals-two-hikes-this-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar on the move after Fed signals two more hikes this year</a></h4><ul><li>Nicely lower minutes ago, the dollar index (<a href='https://seekingalpha.com/symbol/UUP' title='Invesco DB USD Bull ETF'>UUP</a>, <a href='https://seekingalpha.com/symbol/UDN' title='Invesco DB USD Bear ETF'>UDN</a>) is in the green after the FOMC - as expected -<a href=\"https://seekingalpha.com/news/3363712-fed-boosts-funds-rate-25-bps\" target=\"_blank\"> jacked rates by 25 basis points </a>for the 2nd time this year.</li><li>The big question, though, was three hikes or four hikes in 2018? <a href=\"https://www.federalreserve.gov/monetarypolicy/files/fomcprojtabl20180613.pdf\" target=\"_blank\">Checking the dots</a> in the&nbsp; updated economic projections, the median forecast now calls for an end-of-year Fed Funds rate of about 2.5% - meaning two more moves this year.</li><li>Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) is also moving, but pretty modestly. It's dropped about $4 per ounce since the announcement, now<font color='red'> off 0.1%</font>&nbsp;for the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363730\" data-linked=\"Dollar on the move after Fed signals two more hikes this year\" data-tweet=\"$UUP $UDN $GLD - Dollar on the move after Fed signals two more hikes this year https://seekingalpha.com/news/3363730-dollar-on-move-after-fed-signals-two-hikes-this-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3363730-dollar-on-move-after-fed-signals-two-hikes-this-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363728\" data-ts=\"1528914265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDR\" target=\"_blank\">EDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363728-education-realty-trust-in-sale-talks-greystar-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Education Realty Trust in sale talks with Greystar - WSJ</a></h4><ul><li>According to the report, the P-E player has offered $41.50 per share for Education Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/EDR' title='EdR'>EDR</a>).</li><li>Shares are&nbsp;<font color='green'>up 0.7%</font>&nbsp;to $40.38, but were trading at about $36 prior to a June 1 report about a possible sale.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3361160-sudden-jump-education-realty-trust\" target=\"_blank\">Sudden jump for Education Realty Trust</a> (June 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363728\" data-linked=\"Education Realty Trust in sale talks with Greystar - WSJ\" data-tweet=\"$EDR $EDR-OLD - Education Realty Trust in sale talks with Greystar - WSJ https://seekingalpha.com/news/3363728-education-realty-trust-in-sale-talks-greystar-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3363728-education-realty-trust-in-sale-talks-greystar-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363724\" data-ts=\"1528912849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXK\" target=\"_blank\">EXK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363724-energy-materials-top-gainers-losers-of-2-00-pm-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/USAC' title='USA Compression Partners, LP'>USAC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363724\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/13/2018)\" data-tweet=\"$EXK $EXK $LXU - Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/13/2018) https://seekingalpha.com/news/3363724-energy-materials-top-gainers-losers-of-2-00-pm-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363724-energy-materials-top-gainers-losers-of-2-00-pm-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363718\" data-ts=\"1528910967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSAT\" target=\"_blank\">VSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363718-viasat-shores-up-uk-military-presence-horsebridge-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViaSat shores up UK military presence with Horsebridge purchase</a></h4><ul>   <li>ViaSat (<a href=\"http://seekingalpha.com/symbol/VSAT\" target=\"_blank\">VSAT</a> <font color='green'>+1.9%</font>) has <a href=\"https://seekingalpha.com/pr/17190503-viasat-acquires-horsebridge-defence-security-enhance-military-opportunities-uk-defence-forces\" target=\"_blank\">acquired UK-based secure networking firm</a> Horsebridge Defence and Security.</li>    <li>Financial terms weren't disclosed. ViaSat hasn't fully evaluated the acquisition's impact to GAAP earnings.</li>    <li>The company says the add-on enhances military communications integration expertise, allowing for growth the UK defense market.</li>    <li>Horsebridge has built strong relationships with the UK Armed Forces and supports a number of their programs.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363718\" data-linked=\"ViaSat shores up UK military presence with Horsebridge purchase\" data-tweet=\"$VSAT - ViaSat shores up UK military presence with Horsebridge purchase https://seekingalpha.com/news/3363718-viasat-shores-up-uk-military-presence-horsebridge-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3363718-viasat-shores-up-uk-military-presence-horsebridge-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363715\" data-ts=\"1528910111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363715-crispr-therapeutics-gs-presentation-fails-to-excite-investors-shares-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRISPR Therapeutics GS presentation fails to excite investors, shares down 7%</a></h4><ul><li>CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='red'>-6.9%</font>) slumps on more than 40% higher volume following its corporate presentation at Goldman Sachs' Healthcare Conference. Investors are behaving like they were disappointed with what was said.</li><li>CRISPR/Cas9 competitors Intellia Therapeutics (<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='green'>+1.8%</font>) and Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='green'>+1.8%</font>) are holding their own.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363715\" data-linked=\"CRISPR Therapeutics GS presentation fails to excite investors, shares down 7%\" data-tweet=\"$CRSP $CRSP $NTLA - CRISPR Therapeutics GS presentation fails to excite investors, shares down 7% https://seekingalpha.com/news/3363715-crispr-therapeutics-gs-presentation-fails-to-excite-investors-shares-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3363715-crispr-therapeutics-gs-presentation-fails-to-excite-investors-shares-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363711\" data-ts=\"1528909605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363711-boeing-slips-1-on-report-of-possible-order-cancellation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing slips 1% on report of possible order cancellation</a></h4><ul><li>Amid a review of its fleet plans after suffering almost a $2B loss a couple of years back, Etihad Airways is mulling the cancellation or deferment of billions of dollars of 777X orders, according to Reuters.</li><li>The company, according to the report, would be willing to pay penalties rather than face overcapacity.</li><li><a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>&nbsp;<font color='red'>-1.2%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3363711\" data-linked=\"Boeing slips 1% on report of possible order cancellation\" data-tweet=\"$BA - Boeing slips 1% on report of possible order cancellation https://seekingalpha.com/news/3363711-boeing-slips-1-on-report-of-possible-order-cancellation?source=tweet\" data-url=\"https://seekingalpha.com/news/3363711-boeing-slips-1-on-report-of-possible-order-cancellation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363708\" data-ts=\"1528909278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRIV\" target=\"_blank\">YRIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363708-financials-top-5-gainers-losers-of-1-00-pm-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (06/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MFNC' title='Mackinac Financial Corporation'>MFNC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/BCRH' title='Blue Capital Reinsurance Holdings Ltd.'>BCRH</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363708\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (06/13/2018)\" data-tweet=\"$YRIV $YRIV $MFNC - Financials - Top 5 Gainers / Losers as of 1:00 PM (06/13/2018) https://seekingalpha.com/news/3363708-financials-top-5-gainers-losers-of-1-00-pm-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363708-financials-top-5-gainers-losers-of-1-00-pm-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363707\" data-ts=\"1528908778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363707-netflix-clarifies-gaming-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix clarifies gaming plans</a></h4><ul> <li>Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+4.4%</font>) says it's producing an interactive Minecraft series for kids and licensing Stranger Things for a video game. The company's disclosure falls far short of a TechRadar exclusive in which sources said the company is prepping to add games to its subscription service.</li><li>Shares of GameStop (<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color='red'>-4.3%</font>) have tracked back a bit after the Netflix update. It's still possible that longer term plans are in the works at Netflix to integrate games.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363696-gaming-plans-netflix-send-gamestop-lower\" target=\"_blank\">Gaming plans from Netflix send GameStop lower</a> (June 13)</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3363707\" data-linked=\"Netflix clarifies gaming plans\" data-tweet=\"$NFLX $NFLX $GME - Netflix clarifies gaming plans https://seekingalpha.com/news/3363707-netflix-clarifies-gaming-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3363707-netflix-clarifies-gaming-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363705\" data-ts=\"1528908358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363705-midday-gainers-losers-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/13/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/SEII' title='Sharing Economy International Inc.'>OTC:SEII</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/KFY' title='Korn/Ferry International'>KFY</a> <font color='green'>+13%</font>. SHLD <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+11%</font>. COOL <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+9%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='red'>-68%</font>. <a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/SCPH' title='scPharmaceuticals Inc.'>SCPH</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TAL' title='TAL Education Group'>TAL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/USAC' title='USA Compression Partners, LP'>USAC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363705\" data-linked=\"Midday Gainers / Losers (06/13/2018)\" data-tweet=\"$ENPH $ENPH $PVTL - Midday Gainers / Losers (06/13/2018) https://seekingalpha.com/news/3363705-midday-gainers-losers-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363705-midday-gainers-losers-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363703\" data-ts=\"1528907878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363703-videogame-publishers-dip-momentarily-on-netflix-game-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Videogame publishers dip momentarily on Netflix game news</a></h4><ul>   <li>A sudden downblip in the big videogame publishers righted itself almost instantly in the wake of a report that Netflix is planning to <a href=\"https://seekingalpha.com/news/3363696-gaming-plans-netflix-send-gamestop-lower\" target=\"_blank\">add games to its streaming service</a>. (Netflix has clarified that it's adding an \"interactive&nbsp;series\" around <em>Minecraft</em> and is developing one based on <em>Stranger Things,</em> which looks like story-mode video rather than typical console games.)</li>    <li>Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>), Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) and Take-Two Interactive Software (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>) all took a multi-percentage point drop about 25 minutes ago alongside the news, before an instant recovery; algorithmic trading is a likely culprit in the brief volume spike.</li>      <li>With E3 under way, all three are now higher to significantly higher on the day: <a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> <font color='green'>+0.8%</font>; <a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a> <font color='green'>+2.6%</font>; <a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a> <font color='green'>+2.3%</font>. Other publishers are gaining as well: <a href='https://seekingalpha.com/symbol/UBSFY' title='UbiSoft Entertainment Inc. ADR'>OTCPK:UBSFY</a> <font color='green'>+1.7%</font>; <a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga'>ZNGA</a> <font color='green'>+1.1%</font>; <a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a> <font color='green'>+4.1%</font>. The PureFunds Video Game Tech ETF, <a href='https://seekingalpha.com/symbol/GAMR' title='PureFunds Video Game Tech ETF'>GAMR</a>, is <font color='red'>down 0.5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363703\" data-linked=\"Videogame publishers dip momentarily on Netflix game news\" data-tweet=\"$ATVI $ATVI $EA - Videogame publishers dip momentarily on Netflix game news https://seekingalpha.com/news/3363703-videogame-publishers-dip-momentarily-on-netflix-game-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3363703-videogame-publishers-dip-momentarily-on-netflix-game-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363702\" data-ts=\"1528907874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363702-galectin-adds-to-rally-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin adds to rally, up 15%</a></h4><ul><li>MIcro cap Galectin Therapeutics (<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+14.5%</font>) continues its northward march on more than a 5x surge in volume. Shares have more than doubled since mid-May when it announced its plan to advance NASH candidate GR-MD-02 into Phase 3 development.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3356229-galectin-advance-nash-candidate-gr-mdminus-02-phase-3\" target=\"_blank\">Galectin to advance NASH candidate GR-MD-02 into Phase 3</a> (May 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363702\" data-linked=\"Galectin adds to rally, up 15%\" data-tweet=\"$GALT - Galectin adds to rally, up 15% https://seekingalpha.com/news/3363702-galectin-adds-to-rally-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3363702-galectin-adds-to-rally-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363696\" data-ts=\"1528906807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363696-gaming-plans-from-netflix-send-gamestop-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gaming plans from Netflix send GameStop lower</a></h4><ul> <li>Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+4.4%</font>) plans to add games to its service, including a version of Minecraft and a game with a Stranger Things theme, according to a TechRadar <a href=\"https://www.techradar.com/news/netflix-to-add-games-to-its-service-including-stranger-things-and-minecraft\" target=\"_blank\">exclusive</a>.</li> <li>Sources indicate that the games will be delivered through video files and be controlled by a remote equipped with gaming buttons.</li> <li>Netflix will partner with Telltale Games on the project.</li> <li>Shares of Gamestop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) are <font color='red'>down 5.20%</font> in what could be reaction to the Netflix gaming development.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363696\" data-linked=\"Gaming plans from Netflix send GameStop lower\" data-tweet=\"$NFLX $NFLX $GME - Gaming plans from Netflix send GameStop lower https://seekingalpha.com/news/3363696-gaming-plans-from-netflix-send-gamestop-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3363696-gaming-plans-from-netflix-send-gamestop-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363693\" data-ts=\"1528906459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYK\" target=\"_blank\">SYK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363693-madrigal-pharma-up-6-on-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Madrigal Pharma up 6% on takeover chatter</a></h4><ul><li>Takeover rumor mongerers have moved from Stryker (<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a> <font color='green'>+2.7%</font>) and Boston Scientific (<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a> <font color='red'>-5.2%</font>) to Madrigal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+6.4%</font>), up on almost double normal volume.</li><li>Two weeks ago, shares jumped after the company announced positive data on NASH candidate MGL-3196.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360612-madrigals-mglminus-3196-shows-sustained-benefit-mid-stage-nash-study-shares-40-percent\" target=\"_blank\">Madrigal's MGL-3196 shows sustained benefit in mid-stage NASH study; shares up 40% premarket</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363693\" data-linked=\"Madrigal Pharma up 6% on takeover chatter\" data-tweet=\"$SYK $SYK $BSX - Madrigal Pharma up 6% on takeover chatter https://seekingalpha.com/news/3363693-madrigal-pharma-up-6-on-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3363693-madrigal-pharma-up-6-on-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363691\" data-ts=\"1528906026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363691-western-digitalplus-1_5-in-midday-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital +1.5% in midday move</a></h4><ul>   <li>Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='green'>+1.5%</font>) has legged up on no particular news, hitting a session high of $83.44.</li>    <li>That's also its highest point in a week.</li>    <li>Shares are still significantly down (about 22%) from their 2018 high of $106.96, hit on March 16.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363691\" data-linked=\"Western Digital +1.5% in midday move\" data-tweet=\"$WDC - Western Digital +1.5% in midday move https://seekingalpha.com/news/3363691-western-digitalplus-1_5-in-midday-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3363691-western-digitalplus-1_5-in-midday-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363687\" data-ts=\"1528905670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363687-consumer-top-gainers-losers-of-12-00-pm-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (06/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CRWS' title='Crown Crafts, Inc.'>CRWS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363687\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (06/13/2018)\" data-tweet=\"$KNDI $KNDI $CRWS - Consumer - Top Gainers / Losers as of 12:00 PM (06/13/2018) https://seekingalpha.com/news/3363687-consumer-top-gainers-losers-of-12-00-pm-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363687-consumer-top-gainers-losers-of-12-00-pm-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363685\" data-ts=\"1528904633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAC\" target=\"_blank\">PAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363685-ubs-positive-on-grupo-aeroportuario-del-pacifico\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS positive on Grupo Aeroportuario del Pacifico</a></h4><ul> <li>Grupo Aeroportuario del Pacifico (<a href='https://seekingalpha.com/symbol/PAC' title='Grupo Aeroportuario del Pacifico, S.A.B de C.V.'>PAC</a> <font color='green'>+1.9%</font>) trades higher after UBS upgrades the Mexican airport operator to Outperform from Market Perform.</li> <li>Shares of Grupo are down 15% YTD&nbsp;as trade and tariff concerns have entered the equation.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3363685\" data-linked=\"UBS positive on Grupo Aeroportuario del Pacifico\" data-tweet=\"$PAC - UBS positive on Grupo Aeroportuario del Pacifico https://seekingalpha.com/news/3363685-ubs-positive-on-grupo-aeroportuario-del-pacifico?source=tweet\" data-url=\"https://seekingalpha.com/news/3363685-ubs-positive-on-grupo-aeroportuario-del-pacifico\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363684\" data-ts=\"1528904572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BITA\" target=\"_blank\">BITA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363684-bitautoplus-11-after-easy-beat-in-q1-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitauto +11% after easy beat in Q1 earnings</a></h4><ul>   <li>Bitauto (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) is <font color='green'>up 11%</font> in NYSE trading in the regular session, after a solid revenue beat and a surprise profit in its <a href=\"https://seekingalpha.com/news/3363519-bitauto-beats-0_21-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li>    <li>Non-GAAP net income did tumble to 37.lM yuan (about $5.9M) from a year-ago gain of 156.9M yuan. On a GAAP basis, losses swelled to 288.3M yuan from a year-ago loss of 50.1M yuan.</li>    <li>Revenues beat easily after a 52.3% gain in renminbi terms, to 2.17B yuan.</li>    <li>Transaction services revenue more than doubled on high volumes to 1.17B yuan. Advertising and subscription revenues rose 16.3% to 787.5M yuan; and digital marketing solutions revenue rose 28.2% to 211.3M yuan.</li>    <li>For Q2, it's guiding to revenue of 2.47B-2.52B yuan ($393.8M-$401.7M), a Y/Y increase of 23.8%-26.3% in renminbi terms. That's in ASC 606 terms net of VAT; comparing on a gross basis, it would be 2.66B-2.71B yuan, a 22.5%-24.9% increase.</li>    <li><a href=\"https://seekingalpha.com/pr/17190599-bitauto-announces-first-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3363684\" data-linked=\"Bitauto +11% after easy beat in Q1 earnings\" data-tweet=\"$BITA - Bitauto +11% after easy beat in Q1 earnings https://seekingalpha.com/news/3363684-bitautoplus-11-after-easy-beat-in-q1-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3363684-bitautoplus-11-after-easy-beat-in-q1-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363681\" data-ts=\"1528904411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PULM\" target=\"_blank\">PULM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363681-early-stage-study-supports-value-proposition-of-pulmatrixs-pur0200-shares-ahead-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Early-stage study supports value proposition of Pulmatrix&#39;s PUR0200; shares ahead 5%</a></h4><ul><li>Nano cap Pulmatrix (<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='green'>+5.1%</font>) is up on almost triple normal volume in response to <a href=\"https://seekingalpha.com/pr/17191138-pulmatrix-announces-publication-results-phase-1-pharmacodynamic-study-pur0200-copd-patients\" target=\"_blank\">results </a>from a Phase 1 clinical trial assessing lead candidate PUR0200 in patients with moderate-to-severe chronic obstructive pulmonary disease &#40;COPD&#41;.</li><li>PUR0200 achieved a similar therapeutic effect to Boehringer Ingelheim's <a href=\"https://www.spiriva.com/copd/using-spiriva/how-to-use-spiriva-handihaler\" target=\"_blank\">Spiriva HandiHaler</a> (tiotropium bromide) Inhalation Spray at an 83% lower dose with more than 30% less plasma drug exposure.</li><li>The value proposition of PUR0200, an improved inhaled tiotropium bromide, is enhanced efficacy by virtue of its iSPERSE dry powder technology which travels more easily into the lungs.</li><li>The company is co-developing PUR0200 with Vectura Group plc (<a href='https://seekingalpha.com/symbol/VEGPF' title='Vectura Group plc'>OTCPK:VEGPF</a>) for the U.S. market.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3293825-pulmatrix-teams-vectura-develop-copd-candidate-pur0200-shares-3-percent\" target=\"_blank\">Pulmatrix teams up with Vectura to develop COPD candidate PUR0200; shares down 3%</a> (Sept. 6, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363681\" data-linked=\"Early-stage study supports value proposition of Pulmatrix&#39;s PUR0200; shares ahead 5%\" data-tweet=\"$PULM $PULM $VEGPF - Early-stage study supports value proposition of Pulmatrix&#39;s PUR0200; shares ahead 5% https://seekingalpha.com/news/3363681-early-stage-study-supports-value-proposition-of-pulmatrixs-pur0200-shares-ahead-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3363681-early-stage-study-supports-value-proposition-of-pulmatrixs-pur0200-shares-ahead-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363679\" data-ts=\"1528904253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363679-science-applications-slides-6_9-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Science Applications slides 6.9% post Q1 results</a></h4><ul><li>Science Applications (<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-6.9%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4064597\" target=\"_blank\">reports Q1</a> revenue growth of 7.3% Y/Y to 1.2B, the increase was due to revenue on new contracts primarily supporting NASA and the Environmental Protection Agency $47M and increased orders in our supply chain portfolio $64M.</li><li>Operating margin&nbsp;<font color='red'>declined 10 bps</font>&nbsp;to 5.6% &amp; EBITDA margin&nbsp;<font color='red'>declined 10 bps</font>&nbsp;to&nbsp;6.5%, which was driven by higher supply chain material content which generate lower operating margins.</li><li>Cash flows&nbsp;provided by&nbsp;operating activities was $88M, this net increase in working capital investments in platform integration programs supporting the U.S. Navy and Marine Corps was offset by strong customer collections in Q1.</li><li>Deployed&nbsp;$54M&nbsp;of capital, consisting of&nbsp;$32M&nbsp;in plan share repurchases of 0.4M shares, $14M&nbsp;in cash dividends and an&nbsp;$8M&nbsp;term loan repayment.</li><li>Book-to-bill ratio of&nbsp;0.8%, estimated backlog of signed business orders was ~$10B&nbsp;of which$1.9 B&nbsp;was funded.</li><li>Declared a cash dividend of $0.31 per share payable on July 27, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363438-science-applications-beats-0_10-beats-revenue\" target=\"_blank\">Science Applications beats by $0.10, beats on revenue</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363679\" data-linked=\"Science Applications slides 6.9% post Q1 results\" data-tweet=\"$SAIC - Science Applications slides 6.9% post Q1 results https://seekingalpha.com/news/3363679-science-applications-slides-6_9-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3363679-science-applications-slides-6_9-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363680\" data-ts=\"1528904152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363680-enphase-energyplus-32-microinverter-deal-seen-boosting-revenue-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase Energy +32% as microinverter deal seen boosting revenue, margins</a></h4><ul><li>Enphase Energy (<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+32.1%</font>) explodes higher after <a href=\"https://seekingalpha.com/news/3363434-enphase-energy-buy-sunpower-s-microinverter-business\" target=\"_blank\">yesterday's acquisition</a> of SunPower&rsquo;s (<a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='green'>+2.7%</font>) microinverter business in a cash and stock deal.</li><li>ENPH will become the <a href=\"https://www.pv-tech.org/news/sunpower-sells-former-solarbridge-microinverter-business-to-rival-enphase\" target=\"_blank\">exclusive supplier</a> of microinverters to  SPWR, scrapping development of the former SolarBridge products, instead developing a version of its latest  platform technology for SPWR&rsquo;s AC modules.</li><li>The IQ7 is ENPH's seventh generation microinverter platform, and the IQ 7XS microinverter is said to offer 97.5% CEC efficiency and  is designed specifically for SPWR&rsquo;s X Series 96-cell PV  modules, <em>PV&nbsp;Tech</em> explains.</li><li>ENPH hopes the deal will generate an extra $60M-$70M in annual revenue in H2 2019 vs. $286M in total 2017 revenue and boost margins to 33%-35% vs. 19% in 2017.</li><li>For SPWR, the deal is part of a two-year restructuring in an attempt to return to profitability after reporting an $850M loss for FY 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363680\" data-linked=\"Enphase Energy +32% as microinverter deal seen boosting revenue, margins\" data-tweet=\"$ENPH $ENPH $SPWR - Enphase Energy +32% as microinverter deal seen boosting revenue, margins https://seekingalpha.com/news/3363680-enphase-energyplus-32-microinverter-deal-seen-boosting-revenue-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3363680-enphase-energyplus-32-microinverter-deal-seen-boosting-revenue-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363677\" data-ts=\"1528903387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAL\" target=\"_blank\">TAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363677-tal-educationminus-11-after-muddy-waters-attack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TAL Education -11% after Muddy Waters attack</a></h4><ul> <li>TAL Education (NYSE:<a href='https://seekingalpha.com/symbol/TAL' title='TAL Education Group'>TAL</a>) <font color='red'>falls 10.80%</font> after Muddy Waters Research sets its short-selling spotlight on the company.</li> <li>In a nutshell, Muddy Waters alleges that TAL Education has been \"fraudulently\" overstating profits since FY16.</li><li><a href=\"http://muddywatersresearch.com/research/tal/mw-is-short-tal/\" target=\"_blank\">Full Muddy Waters report on TAL.</a></li> <li>If TAL issues a response to the Muddy Waters attack it will be added to the post.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363677\" data-linked=\"TAL Education -11% after Muddy Waters attack\" data-tweet=\"$TAL - TAL Education -11% after Muddy Waters attack https://seekingalpha.com/news/3363677-tal-educationminus-11-after-muddy-waters-attack?source=tweet\" data-url=\"https://seekingalpha.com/news/3363677-tal-educationminus-11-after-muddy-waters-attack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363676\" data-ts=\"1528903342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363676-cramer-and-t-judge-sets-blueprint-for-comcast-media-buying-spree\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cramer: AT&amp;T judge sets &#39;blueprint&#39; for Comcast/media buying spree</a></h4><ul>   <li>In his <a href=\"https://seekingalpha.com/news/3363456-t-prevails-time-warner-merger-trial-without-conditions\" target=\"_blank\">decision on the AT&amp;T case</a>, Judge Richard Leon has <a href=\"https://www.cnbc.com/2018/06/13/cramer-att-time-warner-judge-put-out-blueprint-for-comcast-to-buy-fox.html\" target=\"_blank\">laid out the \"blueprint\"</a> for Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-1.3%</font>) to buy media assets from Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+7.5%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+7.5%</font>), Jim Cramer says.</li>    <li>And not just Comcast, but for other firms to start merging and buying, with the \"ultimate green light\" for vertical mergers.</li>    <li>Cramer reads the judge's commentary around the decision to be \"you can disagree with me but old media better start buying each other quickly because Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+0.6%</font>) and Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.3%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.3%</font>) are going to crush [you].\"</li>    <li>He notes the 172-page opinion was a \"vicious\" rebuke that was an \"embarrassment\" for the Justice Dept.: \"This was brutal.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363676\" data-linked=\"Cramer: AT&amp;T judge sets &#39;blueprint&#39; for Comcast/media buying spree\" data-tweet=\"$FOX $FOX $FOXA - Cramer: AT&amp;T judge sets &#39;blueprint&#39; for Comcast/media buying spree https://seekingalpha.com/news/3363676-cramer-and-t-judge-sets-blueprint-for-comcast-media-buying-spree?source=tweet\" data-url=\"https://seekingalpha.com/news/3363676-cramer-and-t-judge-sets-blueprint-for-comcast-media-buying-spree\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363675\" data-ts=\"1528903339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TBI\" target=\"_blank\">TBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363675-trueblue-acquires-tmp-holdings-ltd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TrueBlue acquires TMP Holdings LTD</a></h4><ul>     <li>TrueBlue (<a href='https://seekingalpha.com/symbol/TBI' title='TrueBlue, Inc.'>TBI</a> <font color='green'>+1.8%</font>) has <a href=\"https://seekingalpha.com/pr/17190723-trueblue-acquires-tmp-holdings-ltd\" target=\"_blank\">acquired</a> TMP Holdings LTD. Terms of the transaction were not disclosed.</li><li>TMP is a leading provider of Recruitment Process Outsourcing, resourcing and recruitment marketing services in the UK.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3363675\" data-linked=\"TrueBlue acquires TMP Holdings LTD\" data-tweet=\"$TBI - TrueBlue acquires TMP Holdings LTD https://seekingalpha.com/news/3363675-trueblue-acquires-tmp-holdings-ltd?source=tweet\" data-url=\"https://seekingalpha.com/news/3363675-trueblue-acquires-tmp-holdings-ltd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363666\" data-ts=\"1528902583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363666-harley-davidson-and-polaris-on-watch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harley-Davidson and Polaris on watch</a></h4><ul> <li>Harley-Davidson (<a href='https://seekingalpha.com/symbol/HOG' title='Harley-Davidson, Inc.'>HOG</a> <font color='green'>+3.1%</font>) and Polaris Industries (<a href='https://seekingalpha.com/symbol/PII' title='Polaris Industries Inc.'>PII</a> <font color='green'>+1.4%</font>) are on watch after Bloomberg tips that M Science is out with a positive note on the vehicle makers.</li> <li>Harley and Polaris have seen some jittery trading over tariff concerns.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3363666\" data-linked=\"Harley-Davidson and Polaris on watch\" data-tweet=\"$HOG $HOG $PII - Harley-Davidson and Polaris on watch https://seekingalpha.com/news/3363666-harley-davidson-and-polaris-on-watch?source=tweet\" data-url=\"https://seekingalpha.com/news/3363666-harley-davidson-and-polaris-on-watch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363663\" data-ts=\"1528902269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LE\" target=\"_blank\">LE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363663-lands-endminus-7-sa-contributor-warns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lands&#39; End -7% as SA contributor warns</a></h4><ul> <li>Lands' End (NASDAQ:<a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a>) is <font color='green'>down 6.85%</font> to cut just a bit into what been's a dizzying 90-day rally of over 75%.</li> <li>Seeking Alpha contributor L&amp;F Capital Management was out with a warning late yesterday on Lands' End ahead of today's dip.</li> <li>\"Although we understand that the fundamentals supporting LE are strengthening, we also feel that this rally is overdone and that valuation is starting to make no sense at present levels,\" wrote L&amp;F.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363663\" data-linked=\"Lands&#39; End -7% as SA contributor warns\" data-tweet=\"$LE - Lands&#39; End -7% as SA contributor warns https://seekingalpha.com/news/3363663-lands-endminus-7-sa-contributor-warns?source=tweet\" data-url=\"https://seekingalpha.com/news/3363663-lands-endminus-7-sa-contributor-warns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363652\" data-ts=\"1528902116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEII\" target=\"_blank\">SEII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363652-sharing-economy-jumps-28-on-new-sharing-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sharing Economy jumps 28% on new sharing agreement</a></h4><ul><li>Sharing Economy International (<a href='https://seekingalpha.com/symbol/SEII' title='Sharing Economy International Inc.'>OTC:SEII</a> <font color='green'>+28.2%</font>)&nbsp;<a href=\"https://www.prnewswire.com/news-releases/sharing-economy-international-enters-into-a-license-agreement-to-establish-ecrent-website-platform-in-north-korea-300665433.html\" target=\"_blank\">announced</a> it entered into a license agreement with Ecrent Capital Holdings, an extensive online global sharing platforms which encourages people to share through renting to protect our environment. The agreement grants of an exclusive and sublicensable license from ECRENT to SEII to utilize certain software and trademarks in order to develop, launch, operate, commercialize, and maintain an online website platform in North Korea.</li><li>SEII will pay Ecrent a maximum of $1M satisfying the condition precedent that the gross profit generated from the corresponding business arrangement in North Korea exceeds the license fee payment.</li><li>The agreement expires on December 31, 2023.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363652\" data-linked=\"Sharing Economy jumps 28% on new sharing agreement\" data-tweet=\"$SEII - Sharing Economy jumps 28% on new sharing agreement https://seekingalpha.com/news/3363652-sharing-economy-jumps-28-on-new-sharing-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3363652-sharing-economy-jumps-28-on-new-sharing-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363659\" data-ts=\"1528902087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363659-healthcare-top-5-gainers-losers-of-11-00-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/PLXP' title='PLx Pharma'>PLXP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='red'>-67%</font>. <a href='https://seekingalpha.com/symbol/SCPH' title='scPharmaceuticals Inc.'>SCPH</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/VRML' title='Vermillion, Inc.'>VRML</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363659\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/13/2018)\" data-tweet=\"$GALT $GALT $PLXP - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/13/2018) https://seekingalpha.com/news/3363659-healthcare-top-5-gainers-losers-of-11-00-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363659-healthcare-top-5-gainers-losers-of-11-00-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363657\" data-ts=\"1528901742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POWI\" target=\"_blank\">POWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363657-power-integrations-gain-from-apple-design-win-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Power Integrations could gain from Apple design win, analyst says</a></h4><ul>     <li>Power Integrations (<a href='https://seekingalpha.com/symbol/POWI' title='Power Integrations, Inc.'>POWI</a> <font color='green'>+3.2%</font>) moves higher in early trading after Rosenblatt analyst Jun Zhang says the company <a href=\"https://twitter.com/thenotablecalls/status/1006893160117792768\" target=\"_blank\">potentially secured a design win</a> for all iPhone and iPad fast charging solutions.</li><li>Apple's (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+0.1%</font>) demand for the fast charging chipset reportedly would total 300M units/year at $0.50-$0.70 per chipset - a \"huge win.\"</li><li>POWI <a href=\"https://twitter.com/thenotablecalls/status/1006893259170254860\" target=\"_blank\">would replace</a> ON&nbsp;Semiconductor (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='green'>+1.2%</font>) and NXP&nbsp;Semiconductors (<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a> <font color='red'>-1.4%</font>) as the main provider for the charging solution for all new iPhones and iPads, and Zhang says Wall Street estimates likely do not reflect this opportunity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363657\" data-linked=\"Power Integrations could gain from Apple design win, analyst says\" data-tweet=\"$POWI $POWI $AAPL - Power Integrations could gain from Apple design win, analyst says https://seekingalpha.com/news/3363657-power-integrations-gain-from-apple-design-win-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3363657-power-integrations-gain-from-apple-design-win-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363655\" data-ts=\"1528901594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TACO\" target=\"_blank\">TACO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363655-wedbush-expects-del-taco-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush expects Del Taco to outperform</a></h4><ul> <li>Wedbush assesses Del Taco (<a href='https://seekingalpha.com/symbol/TACO' title='Del Taco Restaurants, Inc.'>TACO</a> <font color='green'>+0.8%</font>) favorably as it keeps an Outperform rating on the restaurant stock and lifts the price target to <a href=\"https://247wallst.com/services/2018/06/13/why-wedbush-is-betting-big-on-del-taco/\" target=\"_blank\">$17</a> on an expectation for a second-half acceleration.</li><li>The investment firm forecasts 2018 system same-store sales growth of 3.8% for Del Taco, which ranks it second behind Domino's of Wedbush estimates for the restaurant sector.</li> <li>Wedbush digging into the details: \"We expect Q2&rsquo;s tough 6.9% co-owned and 7.5% franchised comp comparisons to be anniversaried with a mid-1% co-owned SSS growth rate and a mid-3% franchised SSS growth rate   We expect the next step of management&rsquo;s &lsquo;Elevated Combined Solutions&rsquo; to launch in early Q3, with an all-new ad campaign accompanying new menu boards, new employee uniforms, and compelling menu innovation, including one or more items at value price points. We view incremental menu price increases towards 3.5% in Q3 and 4% in Q4 (up from 3% in Q2 and 2.5% in Q1), as incremental SSS growth drivers as well.\"</li><li>Shares of Del Taco are up 8.50% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363655\" data-linked=\"Wedbush expects Del Taco to outperform\" data-tweet=\"$TACO - Wedbush expects Del Taco to outperform https://seekingalpha.com/news/3363655-wedbush-expects-del-taco-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3363655-wedbush-expects-del-taco-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363653\" data-ts=\"1528901289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363653-corbus-pharmas-lenabasum-shows-positive-effect-in-extension-phases-of-mid-stage-trials-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corbus Pharma&#39;s lenabasum shows positive effect in extension phases of mid-stage trials in rare autoimmune disorders; shares up 1%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17191115-corbus-pharmaceuticals-presents-1-year-systemic-sclerosis-6-month-dermatomyositis-data-open\" target=\"_blank\">Results </a>from open-label extensions of Phase 2 clinical trials assessing Corbus Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='green'>+0.8%</font>) lenabasum in patients with systemic sclerosis (SSc) and dermatomyositis &#40;DM&#41; showed sustained treatment benefits. The data are being presented at EULAR in Amsterdam.</li><li>At year 1, 77% of SSc patients experienced medically meaningful improvements in a measure of skin thickness called modified Rodnan skin score (mRSS).</li><li>At month 6, 88% of DM patients achieved medically meaningful improvements in a scale called CDASI activity score.</li><li>On the safety front, no serious/severe treatment-related adverse events were reported. The most common adverse events were upper respiratory tract infection (22%), joint pain, skin ulcer and urinary tract infection (14% each) and diarrhea (11%).</li><li>Lenabasum, an oral synthetic endocannabinoid-mimetic, has Orphan Drug and Fast Track status in the U.S. for SSc and Orphan Drug status in Europe for the indication. It is currently being evaluated in a Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03398837?lead=corbus+pharmaceuticals&amp;phase=2&amp;rank=1\" target=\"_blank\">RESOLVE-1</a>, with an estimated completion date of March 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363653\" data-linked=\"Corbus Pharma&#39;s lenabasum shows positive effect in extension phases of mid-stage trials in rare autoimmune disorders; shares up 1%\" data-tweet=\"$CRBP - Corbus Pharma&#39;s lenabasum shows positive effect in extension phases of mid-stage trials in rare autoimmune disorders; shares up 1% https://seekingalpha.com/news/3363653-corbus-pharmas-lenabasum-shows-positive-effect-in-extension-phases-of-mid-stage-trials-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3363653-corbus-pharmas-lenabasum-shows-positive-effect-in-extension-phases-of-mid-stage-trials-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363651\" data-ts=\"1528900808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTC-USD\" target=\"_blank\">BTC-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363651-bitcoin-revisits-2018-low-pain-continues-for-cryptos\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin revisits 2018 low as pain continues for cryptos</a></h4><ul><li>The selloff continues, with Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) down to just above $6,400, and now within a couple of hundred bucks of its February low. <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>&nbsp;<font color='red'>-3.05%</font></li><li>Other coins are faring even worse, with Ether (<a href='https://seekingalpha.com/symbol/ETC-USD' title='Ethereum Classic USD'>ETC-USD</a>)&nbsp;<font color='red'>off another 5%</font>&nbsp;to $470, Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>)&nbsp;<font color='red'>down 6%</font>&nbsp;to $94, and Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>)&nbsp;<font color='red'>sliding 5.5%&nbsp;</font>to $0.52.</li><li>In today's FUD, <a href=\"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3195066\" target=\"_blank\">we have a study out of the University of Texas</a> saying Tether (<a href='https://seekingalpha.com/symbol/USDT-USD' title='Tether USD'>USDT-USD</a>) last year was used to support the price of Bitcoin during its declines. From the study: \"We are able to establish that entities associated with the Bitfinex exchange use tether to purchase bitcoin when prices are falling.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3363651\" data-linked=\"Bitcoin revisits 2018 low as pain continues for cryptos\" data-tweet=\"$BTC-USD $BTC-USD $GBTC - Bitcoin revisits 2018 low as pain continues for cryptos https://seekingalpha.com/news/3363651-bitcoin-revisits-2018-low-pain-continues-for-cryptos?source=tweet\" data-url=\"https://seekingalpha.com/news/3363651-bitcoin-revisits-2018-low-pain-continues-for-cryptos\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>96&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363650\" data-ts=\"1528900401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDC\" target=\"_blank\">FDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363650-first-dataplus-3-analysts-praise-investor-day-commentary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Data +3% as analysts praise investor day commentary</a></h4><ul>     <li>First Data (<a href='https://seekingalpha.com/symbol/FDC' title='First Data Corporation'>FDC</a> <font color='green'>+3.1%</font>) surges at the open following <a href=\"https://www.marketwatch.com/story/first-data-stock-rises-after-analysts-cheer-investor-day-commentary-2018-06-13\" target=\"_blank\">upbeat analyst notes</a> in response to the company's recent investor day.</li>     <li>Mizuho's Thomas McCrohan hikes his stock price target to $25 from $21, citing \"potential for sustained higher growth rates in GBS North America organic revenue, in addition to the longer term prospects for a recovery within the JV channel as well as First Data's ongoing deleveraging effort,\" referring to FDC's global business solutions segment.</li>     <li>Bernstein's Harshita Rawat raises her price target to $24 from $22, believing \"investors will continue to come from the sidelines\" due in part to \"visible signs of operational turnaround\" and a strong trajectory for the Clover business.</li>     <li>Shares climbed 2.8% yesterday after a <a href=\"https://seekingalpha.com/news/3363212-goldman-upgrades-first-data-buy-price-target-25\" target=\"_blank\">Goldman Sachs upgrade</a>, as the firm expects revenue growth to improve as the acquisition of CardConnect and BluePay would triple FDC's exposure to sales coming from independent software vendors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363650\" data-linked=\"First Data +3% as analysts praise investor day commentary\" data-tweet=\"$FDC - First Data +3% as analysts praise investor day commentary https://seekingalpha.com/news/3363650-first-dataplus-3-analysts-praise-investor-day-commentary?source=tweet\" data-url=\"https://seekingalpha.com/news/3363650-first-dataplus-3-analysts-praise-investor-day-commentary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363646\" data-ts=\"1528900012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRWS\" target=\"_blank\">CRWS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363646-crown-craftsplus-10-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crown Crafts +10% after earnings</a></h4><ul> <li>Shares of Crown Crafts (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWS' title='Crown Crafts, Inc.'>CRWS</a>) are <font color='green'>up 9.73%</font> in morning trading after the company beat analyst estimates with its FQ4 report.</li> <li>As expected, the bankruptcy of Toys \"R\" Us had a negative impact on the company's results, although perhaps not as severe as anticipated.</li> <li>CEO update: \"We now have a robust, direct-to-consumer sales channel through Carousel Designs, and we have expanded into new categories through the acquisition of Sassy. Both brands are well known and highly regarded in the industry, and we are thrilled to have them contributing to the future of Crown Crafts.\"</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3363524-crown-crafts-reports-q4-results\" target=\"_blank\">Crown Crafts reports Q4 results</a> (June 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363646\" data-linked=\"Crown Crafts +10% after earnings\" data-tweet=\"$CRWS - Crown Crafts +10% after earnings https://seekingalpha.com/news/3363646-crown-craftsplus-10-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3363646-crown-craftsplus-10-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363642\" data-ts=\"1528899755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTCOF\" target=\"_blank\">ZTCOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363642-wsj-white-house-opposes-senate-effort-to-kill-zte-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: White House opposes Senate effort to kill ZTE deal</a></h4><ul>   <li>The Trump administration is looking to <a href=\"https://www.wsj.com/articles/white-house-seeks-to-block-senate-bid-to-kill-zte-deal-1528897896?mod=hp_lead_pos4\" target=\"_blank\">block Senate language</a> that would undo a White House deal to resuscitate China's ZTE (<a href=\"http://seekingalpha.com/symbol/ZTCOF\" target=\"_blank\">ZTCOF</a> <font color='red'>-7.1%</font>), <i>The Wall Street Journal</i> reports.</li>    <li>The usually sure-passing National Defense Authorization Act contains language rebuking the White House for its ZTE deal.</li>    <li>But an official says the White House will look to change the anti-deal language while the House and Senate hold a conference to sort out differences between their two bills.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363642\" data-linked=\"WSJ: White House opposes Senate effort to kill ZTE deal\" data-tweet=\"$ZTCOF - WSJ: White House opposes Senate effort to kill ZTE deal https://seekingalpha.com/news/3363642-wsj-white-house-opposes-senate-effort-to-kill-zte-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3363642-wsj-white-house-opposes-senate-effort-to-kill-zte-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363621\" data-ts=\"1528898514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KFY\" target=\"_blank\">KFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363621-all-time-high-for-korn-ferry-after-strong-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">All-time high for Korn/Ferry after strong earnings</a></h4><ul> <li>Korn/Ferry International (NYSE:<a href='https://seekingalpha.com/symbol/KFY' title='Korn/Ferry International'>KFY</a>) is<font color='green'> up 15.99%</font>&nbsp;after investors jump on board following the company's Q1 earnings topper.</li> <li>The <a href=\"https://seekingalpha.com/pr/17190835-korn-ferry-international-announces-fourth-quarter-fiscal-2018-results-operations\" target=\"_blank\">FQ4</a> EPS markf of $0.80 topped even the highest analyst estimate, according to Bloomberg.</li> <li>\"We achieved the highest fiscal year fee revenue in our firm's history &ndash; up 13% year over year,\" says Korn CEO Gary Burnison on the quarter.</li> <li>Shares of KFY hit a record high of $68.34 a bit earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363621\" data-linked=\"All-time high for Korn/Ferry after strong earnings\" data-tweet=\"$KFY - All-time high for Korn/Ferry after strong earnings https://seekingalpha.com/news/3363621-all-time-high-for-korn-ferry-after-strong-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3363621-all-time-high-for-korn-ferry-after-strong-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363614\" data-ts=\"1528897816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSCI\" target=\"_blank\">WSCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363614-on-wsi-industries-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on WSI Industries Q3 results</a></h4><div><ul><li>WSI Industries (<a href='https://seekingalpha.com/symbol/WSCI' title='WSI Industries Inc.'>WSCI</a> <font color='green'>+1.9%</font>) reported Q3 sales of $9.79M (+2.1% Y/Y). Company&rsquo;s Diversified group, which includes energy, aerospace, defense and industrial markets increased sales by 78% Y/Y, whereas sales to the largest customer were down compared to last year due to one-time sale of inventory on a discontinued product line in the prior year quarter.</li><li>Q3 Overall gross margin&nbsp;<font color='green'>improved by 406 bps</font>&nbsp;to 14.8%.</li><li>SG&amp;A expenses decreased by 30% Y/Y to $0.83M.</li><li>Cash and cash equivalents were $4.92M as of May 27, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363442-wsi-industries-reports-q3-results\" target=\"_blank\">WSI Industries reports Q3 results</a> (June 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363568-wsi-industries-declares-0_04-dividend\" target=\"_blank\">WSI Industries declares $0.04 dividend</a> (June 13)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3363614\" data-linked=\"More on WSI Industries Q3 results\" data-tweet=\"$WSCI - More on WSI Industries Q3 results https://seekingalpha.com/news/3363614-on-wsi-industries-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3363614-on-wsi-industries-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363612\" data-ts=\"1528897315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBTYA\" target=\"_blank\">LBTYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363612-liberty-globalminus-2_1-on-new-sell-berenberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Global -2.1% on new Sell at Berenberg</a></h4><ul>   <li>Liberty Global (<a href=\"http://seekingalpha.com/symbol/LBTYA\" target=\"_blank\">LBTYA</a> <font color='red'>-2.1%</font>) is lower out of the open after an initiation at Sell by Berenberg.</li>    <li>With disposals planned by the company leaving it in saturated markets, it's time to look at a lower-growth situation, the firm says. It expects a revenue decline in three of Liberty's four continuing major markets: Switzerland, Belgium and the Netherlands. (h/t Bloomberg)</li>    <li>Berenberg has a price target of $26, implying 12% downside from current pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363612\" data-linked=\"Liberty Global -2.1% on new Sell at Berenberg\" data-tweet=\"$LBTYA $LBTYB $LBTYK - Liberty Global -2.1% on new Sell at Berenberg https://seekingalpha.com/news/3363612-liberty-globalminus-2_1-on-new-sell-berenberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3363612-liberty-globalminus-2_1-on-new-sell-berenberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363610\" data-ts=\"1528897014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363610-sarepta-partners-brammer-bio-to-manufacture-gene-therapies-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta partners with Brammer Bio to manufacture gene therapies; shares up 1%</a></h4><ul><li>Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+1%</font>) inks a long-term <a href=\"https://seekingalpha.com/pr/17190904-sarepta-therapeutics-enters-long-term-strategic-manufacturing-partnership-brammer-bio-support\" target=\"_blank\">agreement </a>with privately held Cambridge, MA-based <a href=\"https://www.brammerbio.com/\" target=\"_blank\">Brammer Bio</a>&nbsp;for the manufacture of gene therapies, including its micro-dystrophin DMD gene therapy.</li><li>The company calls the partnership a hybrid manufacturing and development model because it relies on both internal and external input. Specifically, Sarepta will continue to build its internal expertise in AAV-based manufacturing while Brammer will provide scalable manufacturing capabilities. The companies will collaborate on integrating process development, clinical production and testing and commercial manufacturing. Brammer will assist Sarepta in designing and building dedicated manufacturing within Sarepta.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363610\" data-linked=\"Sarepta partners with Brammer Bio to manufacture gene therapies; shares up 1%\" data-tweet=\"$SRPT - Sarepta partners with Brammer Bio to manufacture gene therapies; shares up 1% https://seekingalpha.com/news/3363610-sarepta-partners-brammer-bio-to-manufacture-gene-therapies-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3363610-sarepta-partners-brammer-bio-to-manufacture-gene-therapies-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363602\" data-ts=\"1528896331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363602-comcast-slashed-to-neutral-raymond-james-sharesminus-4_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast slashed to Neutral by Raymond James; shares -4.3%</a></h4><ul>   <li>Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) is <font color='red'>down 4.3%</font> premarket following a downgrade to Market Perform from Strong Buy by Raymond James.</li>    <li>Aside from the downgrade, though, the move mirrors the stock's <a href=\"https://seekingalpha.com/news/3363481-aftermarket-trade-ripples-run-wide-and-t-time-warner-decision\" target=\"_blank\">after-hours decline yesterday</a> in the wake of AT&amp;T's <a href=\"https://seekingalpha.com/news/3363456-t-prevails-time-warner-merger-trial-without-conditions\" target=\"_blank\">win in its antitrust case</a>, an outcome that presages Comcast's full bid for Fox media assets.</li>    <li>While a number of media stocks and potential merger partners jumped in the aftermath of the decision, Comcast and Disney traded lower as they seemed headed toward a bidding war for the Fox assets as well as locking horns for Sky. Premarket: <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='red'>-2.1%</font>; <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+7.1%</font>; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+7.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363602\" data-linked=\"Comcast slashed to Neutral by Raymond James; shares -4.3%\" data-tweet=\"$CMCSA $CMCSA $DIS - Comcast slashed to Neutral by Raymond James; shares -4.3% https://seekingalpha.com/news/3363602-comcast-slashed-to-neutral-raymond-james-sharesminus-4_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3363602-comcast-slashed-to-neutral-raymond-james-sharesminus-4_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363601\" data-ts=\"1528896184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLKS\" target=\"_blank\">FLKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363601-premarket-losers-of-9-05-6-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (6/13/2018)</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a>&nbsp;<font color='red'>-67%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3363567-flex-pharma-bails-development-lead-candidate-als-cmt-shares-61-percent-premarket\" target=\"_blank\">ending</a> its Phase 2 clinical trial investigations of FLX-787 in ALS and CMT.</li><li><a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>&nbsp;<font color='red'>-36%</font>&nbsp;after its announcement to <a href=\"https://seekingalpha.com/news/3363465-t-applauds-decision-looks-close-time-warner-june-20\" target=\"_blank\">close</a> Time Warner deal.</li><li><a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a>&nbsp;<font color='red'>-23%</font>&nbsp;after azeliragon <a href=\"https://seekingalpha.com/news/3363459-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study-shares-halted\" target=\"_blank\">fails</a> late-stage Alzheimer's study.</li><li><a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a>&nbsp;<font color='red'>-19%</font>&nbsp;after disappointing <a href=\"https://seekingalpha.com/news/3363559-h-and-r-block-minus-18-percent-disappointing-guidance\" target=\"_blank\">guidance</a>.</li><li><a href='https://seekingalpha.com/symbol/SCPH' title='scPharmaceuticals Inc.'>SCPH</a>&nbsp;<font color='red'>-17%</font>&nbsp;after&nbsp;FDA <a href=\"https://seekingalpha.com/news/3363584-fda-rejects-scpharmas-furoscix-application-shares-9-percent-premarket\" target=\"_blank\">rejects</a> Furoscix application.</li><li><a href='https://seekingalpha.com/symbol/USAC' title='USA Compression Partners, LP'>USAC</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3363556-usa-compression-minus-9-percent-secondary-offering\" target=\"_blank\">pricing</a> secondary offering.</li><li><a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a>&nbsp;<font color='red'>-7%</font>&nbsp;after Stryker <a href=\"https://seekingalpha.com/news/3363579-stryker-6-percent-premarket-merger-discussions-boston-scientific-bsx-7-percent\" target=\"_blank\">announces</a> that it is not in merger talks with BSX.</li><li><a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-4%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363601\" data-linked=\"Premarket Losers as of 9:05 am (6/13/2018)\" data-tweet=\"$FLKS $SLRX $T - Premarket Losers as of 9:05 am (6/13/2018) https://seekingalpha.com/news/3363601-premarket-losers-of-9-05-6-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363601-premarket-losers-of-9-05-6-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363600\" data-ts=\"1528896171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363600-premarket-gainers-of-9-05-06-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (06/13/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+32%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3363434-enphase-energy-buy-sunpower-s-microinverter-business\" target=\"_blank\">buying</a> SunPower&rsquo;s microinverter business.</li>     <li><a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+16%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SEII' title='Sharing Economy International Inc.'>OTC:SEII</a> <font color='green'>+13%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='green'>+11%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/pr/17190891-vistagen-therapeutics-issued-two-key-u-s-patents-treatment-depression-avminus-101\" target=\"_blank\">two key&nbsp;U.S.</a><a href=\"https://seekingalpha.com/pr/17190891-vistagen-therapeutics-issued-two-key-u-s-patents-treatment-depression-avminus-101\" target=\"_blank\">&nbsp;patents</a> related to AV-101.</li>     <li><a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a> <font color='green'>+11%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3363431-pivotal-software-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17190888-oragenics-inc-announces-peer-reviewed-publication-detailing-discovery-og716-c-difficile\" target=\"_blank\">announcing</a> the publication of a research paper entitled &ldquo;OG716: designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections\".</li>     <li><a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a> <font color='green'>+8%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3363519-bitauto-beats-0_21-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+7%</font>&nbsp;as they could <a href=\"https://seekingalpha.com/news/3363503-stock-watch-ahead-world-cup\" target=\"_blank\">benefit</a> from world cup.</li>     <li><a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+7%</font>&nbsp;as they could&nbsp;<a href=\"https://seekingalpha.com/news/3363503-stock-watch-ahead-world-cup\" target=\"_blank\">benefit</a>&nbsp;from world cup.</li>     <li><a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3363579-stryker-6-percent-premarket-merger-discussions-boston-scientific-bsx-7-percent\" target=\"_blank\">no merger discussions</a> with Boston Scientific.</li>     <li><a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='green'>+5%</font>&nbsp;as mega-merger healthcare players up on <a href=\"https://seekingalpha.com/news/3363466-mega-merger-healthcare-players-positive-court-ruling-and-t-time-warner-tie\" target=\"_blank\">positive court ruling</a> for AT&amp;T/Time Warner tie-up.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363600\" data-linked=\"Premarket Gainers as of 9:05 am (06/13/2018)\" data-tweet=\"$ENPH $ENPH $CANF - Premarket Gainers as of 9:05 am (06/13/2018) https://seekingalpha.com/news/3363600-premarket-gainers-of-9-05-06-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363600-premarket-gainers-of-9-05-06-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363598\" data-ts=\"1528895769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363598-yelp-down-nearly-3-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp down nearly 3% after downgrade</a></h4><ul><li>Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) now has two Sell ratings among the 31 sell-siders covering, as Aegis' Victor Anthony downgrades. His $34 price target is the lowest on the Street, and suggests about<font color='red'> 20% downside</font>&nbsp;from yesterday's close.</li><li>The potential for rising costs and lower revenue per account could \"stress Yelp's model,\" says Anthony.</li><li>He's not a fan of the Request-a-Quote feature, arguing it's likely to be \"cannibalistic\" to local advertising.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='red'>down 2.8%</font>&nbsp;to $41.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363598\" data-linked=\"Yelp down nearly 3% after downgrade\" data-tweet=\"$YELP - Yelp down nearly 3% after downgrade https://seekingalpha.com/news/3363598-yelp-down-nearly-3-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3363598-yelp-down-nearly-3-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363588\" data-ts=\"1528894625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBS\" target=\"_blank\">EBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363588-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Emergent BioSolutions (NYSE:<a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a>) initiated with Buy rating and $62 (15% upside) price target at Argus Research.</li><li>Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a>) downgraded to Hold with a $2 (9% upside) price target at Jefferies.</li><li>ARMO BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ARMO' title='ARMO BioSciences, Inc.'>ARMO</a>) downgraded to Hold with a $50 (flat) price target at Jefferies.</li><li>Envision Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/EVHC' title='Envision Healthcare Holdings'>EVHC</a>) downgraded to Hold with a $46 (3% upside) price target at Canaccord Genuity after KKR's $46/share bid.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363588\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$EBS $EBS $ADXS - Premarket analyst action - healthcare https://seekingalpha.com/news/3363588-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3363588-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363584\" data-ts=\"1528894161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCPH\" target=\"_blank\">SCPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363584-fda-rejects-scpharmas-furoscix-application-shares-down-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects scPharma&#39;s Furoscix application, shares down 9% premarket</a></h4><ul><li>Thinly traded micro cap scPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SCPH' title='scPharmaceuticals Inc.'>SCPH</a>) is down&nbsp;<font color='red'>9%</font>&nbsp;premarket in response to its <a href=\"https://seekingalpha.com/pr/17190779-scpharmaceuticals-receives-complete-response-letter-fda-furoscix\" target=\"_blank\">announcement</a> that it received a CRL from the FDA regarding its marketing application seeking approval for FUROSCIX Infusor (furosemide) for the treatment of fluid overload (edema) in heart failure patients.</li><li>The CRL cited the need for additional human factor studies, device modifications and, potentially, a new clinical study. The company intends to request a meeting with the agency to sort out the issues.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360700-scpharmaceuticals-30-percent-premarket-delay-nda-furoscix-infusor\" target=\"_blank\">ScPharmaceuticals down 30% premarket on delay of NDA for Furoscix Infusor</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363584\" data-linked=\"FDA rejects scPharma&#39;s Furoscix application, shares down 9% premarket\" data-tweet=\"$SCPH - FDA rejects scPharma&#39;s Furoscix application, shares down 9% premarket https://seekingalpha.com/news/3363584-fda-rejects-scpharmas-furoscix-application-shares-down-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3363584-fda-rejects-scpharmas-furoscix-application-shares-down-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363583\" data-ts=\"1528894121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363583-twitter-higher-kim-kardashian-pushes-editbutton\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter higher as Kim Kardashian pushes #editbutton</a></h4><ul><li>\"I had a very good convo with [CEO Jack Dorsey] this weekend at Kanye&rsquo;s bday and I think he really heard me out on the edit button,\" <a href=\"https://twitter.com/KimKardashian/status/1006691477471125504\" target=\"_blank\">tweeted</a> Kim Kardashian West last night.</li><li><a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>&nbsp;<font color='green'>+1.85%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3363583\" data-linked=\"Twitter higher as Kim Kardashian pushes #editbutton\" data-tweet=\"$TWTR - Twitter higher as Kim Kardashian pushes #editbutton https://seekingalpha.com/news/3363583-twitter-higher-kim-kardashian-pushes-editbutton?source=tweet\" data-url=\"https://seekingalpha.com/news/3363583-twitter-higher-kim-kardashian-pushes-editbutton\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363579\" data-ts=\"1528893748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYK\" target=\"_blank\">SYK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363579-stryker-up-6-premarket-on-no-merger-discussions-boston-scientific-bsx-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stryker up 6% premarket on no merger discussions with Boston Scientific, BSX down 7%</a></h4><ul><li>Stryker (NYSE:<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket while Boston Scientific (NYSE:<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a>)&nbsp;is down&nbsp;<font color='red'>7%</font>&nbsp;on the heels of the former's <a href=\"https://seekingalpha.com/filing/4065429\" target=\"_blank\">disclosure </a>that it is not in merger talks with BSX.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363008-boston-scientific-7-percent-rumored-stryker-interest\" target=\"_blank\">Boston Scientific up 7% on rumored Stryker interest</a> (June 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363579\" data-linked=\"Stryker up 6% premarket on no merger discussions with Boston Scientific, BSX down 7%\" data-tweet=\"$SYK $SYK $BSX - Stryker up 6% premarket on no merger discussions with Boston Scientific, BSX down 7% https://seekingalpha.com/news/3363579-stryker-up-6-premarket-on-no-merger-discussions-boston-scientific-bsx-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3363579-stryker-up-6-premarket-on-no-merger-discussions-boston-scientific-bsx-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363567\" data-ts=\"1528892181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLKS\" target=\"_blank\">FLKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363567-flex-pharma-bails-on-development-of-lead-candidate-in-als-and-cmt-shares-down-61-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flex Pharma bails on development of lead candidate in ALS and CMT; shares down 61% premarket</a></h4><ul><li>Thinly traded nano cap Flex Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a>) craters&nbsp;<font color='red'>61%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17190629-flex-pharma-announces-corporate-update\" target=\"_blank\">announcement </a>that it has terminated its Phase 2 clinical trials evaluating lead drug FLX-787 in amyotrophic lateral sclerosis &#40;ALS&#41; and Charcot-Marie-Tooth &#40;CMT&#41; due to oral tolerability concerns in a subset of patients who received the 30 mg oral disintegrating tablet three times per day.</li><li>The company says more formulation and dose-ranging studies need to done which, apparently, are beyond its current level of resources. As such, it will downsize 60% and evaluate strategic alternatives. Wedbush PacGrow will advise.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363567\" data-linked=\"Flex Pharma bails on development of lead candidate in ALS and CMT; shares down 61% premarket\" data-tweet=\"$FLKS $SLRX - Flex Pharma bails on development of lead candidate in ALS and CMT; shares down 61% premarket https://seekingalpha.com/news/3363567-flex-pharma-bails-on-development-of-lead-candidate-in-als-and-cmt-shares-down-61-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3363567-flex-pharma-bails-on-development-of-lead-candidate-in-als-and-cmt-shares-down-61-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363562\" data-ts=\"1528891798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KFY\" target=\"_blank\">KFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363562-korn-ferry-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Korn/Ferry beats by $0.10, beats on revenue</a></h4><ul><li>Korn/Ferry (NYSE:<a href='https://seekingalpha.com/symbol/KFY' title='Korn/Ferry International'>KFY</a>): Q4 EPS of $0.80 <font color='green'>beats by $0.10</font>.</li><li>Revenue of $475.36M (+17.1% Y/Y) <font color='green'>beats by $16.98M</font>.</li><li>Shares <font color='green'>+6.05%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17190835-korn-ferry-international-announces-fourth-quarter-fiscal-2018-results-operations'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3363562\" data-linked=\"Korn/Ferry beats by $0.10, beats on revenue\" data-tweet=\"$KFY - Korn/Ferry beats by $0.10, beats on revenue https://seekingalpha.com/news/3363562-korn-ferry-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3363562-korn-ferry-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363559\" data-ts=\"1528891494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRB\" target=\"_blank\">HRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363559-h-and-r-blockminus-18-after-disappointing-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H&amp;R Block -18% after disappointing guidance</a></h4><ul> <li>H&amp;R Block (NYSE:<a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a>) is <font color='red'>down 18%</font> in premarket trading after issuing guidance that fell short of expectations.</li> <li>The company expects FY19 revenue of $3.05B to $3.10B vs. $3.14B consensus and sees margins dropping to 24% to 26%.</li> <li><a href=\"https://seekingalpha.com/article/4181210-h-and-r-block-inc-hrb-ceo-jeffrey-jones-q4-2018-results-earnings-call-transcript\" target=\"_blank\">H&amp;R Block earnings call transcript</a></li> <li>Previously: <a href=\"https://seekingalpha.com/news/3363436-h-and-amp-r-block-beats-0_16-beats-revenue\" target=\"_blank\">H&amp;R Block beats by $0.16, beats on revenue</a> (June 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363559\" data-linked=\"H&amp;R Block -18% after disappointing guidance\" data-tweet=\"$HRB - H&amp;R Block -18% after disappointing guidance https://seekingalpha.com/news/3363559-h-and-r-blockminus-18-after-disappointing-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3363559-h-and-r-blockminus-18-after-disappointing-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363556\" data-ts=\"1528891030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAC\" target=\"_blank\">USAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363556-usa-compressionminus-9-after-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USA Compression -9% after secondary offering</a></h4><ul>     <li>USA&nbsp;Compression (NYSE:<a href='https://seekingalpha.com/symbol/USAC' title='USA Compression Partners, LP'>USAC</a>) <font color='red'>-8.7%</font> premarket after pricing a <a href=\"https://seekingalpha.com/pr/17190439-usa-compression-partners-lp-announces-pricing-secondary-offering-common-units\" target=\"_blank\">5M-share secondary offering</a> for ~$81M in total gross proceeds to the selling unitholder.</li>     <li>USAC will not receive any proceeds from the sale of units in the offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363556\" data-linked=\"USA Compression -9% after secondary offering\" data-tweet=\"$USAC - USA Compression -9% after secondary offering https://seekingalpha.com/news/3363556-usa-compressionminus-9-after-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3363556-usa-compressionminus-9-after-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363550\" data-ts=\"1528890393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363550-asml-upgraded-rbc-amat-and-lam-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ASML upgraded at RBC; AMAT and Lam cut</a></h4><ul><li>With customers like Samsung and Taiwan Semi likely to at best hold investment flat, 2019 is shaping up as a \"muted year\" for the semiconductor equipment industry, says the team at RBC.</li><li>Downgraded to Sector Perform from Outperform are Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) and Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>). Top pick in the sector is ASML Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a>), which is upgraded to Outperform.</li><li>ASML&nbsp;<font color='green'>+1.7%</font>, AMAT&nbsp;<font color='red'>-1.3%</font>, LRCX&nbsp;<font color='red'>-1.3%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3363550\" data-linked=\"ASML upgraded at RBC; AMAT and Lam cut\" data-tweet=\"$AMAT $AMAT $LRCX - ASML upgraded at RBC; AMAT and Lam cut https://seekingalpha.com/news/3363550-asml-upgraded-rbc-amat-and-lam-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3363550-asml-upgraded-rbc-amat-and-lam-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363533\" data-ts=\"1528888441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363533-fda-grants-accelerated-review-for-mercks-gardasil-application-for-expanded-age-indication\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA grants accelerated review for Merck&#39;s Gardasil application for expanded age indication; shares up 1% premarket</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17190618-fda-grants-priority-review-merck-s-supplemental-biologics-license-application-sbla-gardasil-9\" target=\"_blank\">accepts </a>under Priority Review Merck's (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) marketing application seeking approval for GARDASIL 9 (human papillomavirus 9-valent vaccine, recombinant) for use in women and men ages 27-45 for the prevention of certain cancers and diseases caused by the nine human papillomavirus &#40;HPV&#41; types covered by the vaccine. The agency's action date is October 6.</li><li>Gardasil is currently approved for girls and women ages 9-26 and boys and men ages 9-26.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363533\" data-linked=\"FDA grants accelerated review for Merck&#39;s Gardasil application for expanded age indication; shares up 1% premarket\" data-tweet=\"$MRK - FDA grants accelerated review for Merck&#39;s Gardasil application for expanded age indication; shares up 1% premarket https://seekingalpha.com/news/3363533-fda-grants-accelerated-review-for-mercks-gardasil-application-for-expanded-age-indication?source=tweet\" data-url=\"https://seekingalpha.com/news/3363533-fda-grants-accelerated-review-for-mercks-gardasil-application-for-expanded-age-indication\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363532\" data-ts=\"1528888328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363532-strong-call-from-goldman-sachs-on-netflix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong call from Goldman Sachs on Netflix</a></h4><ul> <li>Goldman Sachs lifts its price target on Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) to a Street-high $490 after having it set at $390.</li> <li>The investment firm maintains its Buy rating on the streamer as it points to a strong case of NFLX&nbsp;fundamentals catching up to expectations.</li> <li>Shares of Netflix are <font color='green'>up 2.19%</font> in premarket trading to $371.78.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363532\" data-linked=\"Strong call from Goldman Sachs on Netflix\" data-tweet=\"$NFLX - Strong call from Goldman Sachs on Netflix https://seekingalpha.com/news/3363532-strong-call-from-goldman-sachs-on-netflix?source=tweet\" data-url=\"https://seekingalpha.com/news/3363532-strong-call-from-goldman-sachs-on-netflix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}